4,050
Jobs currently available
366
Portfolio companies
Locations
Cambridge, MA, USA
industry
Biotechnology · DeepTech · Health
Size
1 - 10 employees
Stage
Series B
founded in
2016
SURGE Therapeutics seeks to dramatically improve cancer patient survival by disrupting cancer immunotherapy is deployed. The company provides an injectable biodegradable hydrogel that allows for the prolonged, localized release of most cancer immunotherapy on the website of surgical tumor resection by focusing the dose at the right place and right time.
Something looks off?